Product
Clinical Studies
GPC201(GPC-100 + Propranolol)
Study No.
NCT05561751
Country / Phase
US / Phase II
Condition
Stem cell mobilization for autologous transplantation in multiple myeloma
Status
On-going
Title of Study
A Phase 2, Randomized, Open-Label Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
GPC-100
Study No.
NNCT00822341
NCT02104427
Country / Phase
US / Phase I
US / Phase II
Condition
Stem cell mobilization in Healthy volunteers
Stem cell mobilization for autologous transplantation in multiple myeloma, Non-Hodgkin lymphoma or Hodgkin disease
Status
Completed
Completed
Title of Study
A Randomized, Double-Blind, Placebo-Controlled, Sequential Ascending Single Intravenous Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TG-0054 in Health Subjects
A Phase II, Open-Label Study to Evaluate the Hematopoietic Stem Cell Mobilization of TG-0054 Combined with G-CSF in Patients with Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease